Catalyst Wire Dossier Catalyst Wire Dossier

NeuroBloc

botulinum toxin type B · Sloan Pharma S.a.r.l
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NeuroBloc, covering 2023-05-04 to 2023-05-04. Get the full timeline:

Most recent: EMA Withdrawn: NeuroBloc (botulinum toxin type B) — Sloan Pharma S.a.r.l

See pricing